History
  • No items yet
midpage
Federal Trade Commission v. Abbvie Products LLC
713 F.3d 54
| 11th Cir. | 2013
Read the full case

Background

  • FTC investigated the Solvay/AbbVie reverse-payment settlement for antitrust concerns related to AndroGel profits.
  • Tulip FA, a confidential Tulip Financial Analysis, was produced by Solvay and attached as the sole exhibit to the FTC’s complaint.
  • District court sealed Tulip FA in 2010 based on good cause due to sensitive information.
  • FTC and amici requested unsealing for Supreme Court briefing; district court found public interest outweighed Solvay’s confidentiality over time.
  • Panel affirmed earlier Watson decision; Supreme Court later granted certiorari in Actavis, limiting the issue to reverse-payment legality.
  • Court reviews district court’s protective-order modification for abuse of discretion; standard is good-cause balancing under Chicago Tribune, not de novo review.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether Tulip FA is a judicial record subject to public access Solvay contends Tulip FA is confidential, not a judicial record FTC argues Tulip FA attached to complaint is a judicial record Tulip FA is a judicial record and presumptively public.
Appropriate standard to modify protective order—good cause vs extraordinary circumstances District court should apply extraordinary-circumstances test Burden on FTC under good-cause balancing; Solvay invited error if misapplied District court did not abuse discretion; burden on FTC to show good cause; no error in applying Chicago Tribune standard.
Whether district court adequately considered reliance on the protective order Solvay relied on FTC confidentiality promises Reliance analysis not required given timing and unilateral disclosure by Solvay District court properly analyzed reliance within the good-cause framework; no abuse.
Whether the balance of equities supported unsealing Confidential data protects Solvay’s pricing and rebates Public interest in understanding antitrust issues and judicial process outweighs confidentiality Public interest outweighed Solvay’s confidentiality; unsealing appropriate.
Whether the district court’s factual findings about reduced risk of competitive injury were clearly erroneous Tulip FA still sensitive and could injure Solvay Time has reduced risk; updated product versions alter cost structure No clear error; findings plausible and supported by record.

Key Cases Cited

  • Chicago Tribune Co. v. Bridgestone/Firestone, Inc., 263 F.3d 1304 (11th Cir. 2001) (balancing test for public access to judicial records; discovery materials generally exempt from public access)
  • In re Agent Orange Prod. Liab. Litig., 821 F.2d 139 (2d Cir. 1987) (protective-order modification and disclosure considerations; abuse of discretion standards)
  • Nixon v. Warner Commc’ns, 435 U.S. 589 (1978) (access decisions rests in discretion of trial court; abuse of discretion review standard)
  • United States v. Amodeo, 71 F.3d 1049 (2d Cir. 1995) (continuum approach to public-access determinations; importance of judicial function)
Read the full case

Case Details

Case Name: Federal Trade Commission v. Abbvie Products LLC
Court Name: Court of Appeals for the Eleventh Circuit
Date Published: Mar 21, 2013
Citation: 713 F.3d 54
Docket Number: 12-16488
Court Abbreviation: 11th Cir.